Neoton

Neoton is a pharmaceutical company primarily known for the development and commercialization of its flagship product, Neoton (exogenous creatine phosphate). The company focuses on cardiovascular health, providing therapeutic solutions for myocardial protection during cardiac surgery and the treatment of acute and chronic heart failure. Neoton's core product works by restoring high-energy phosphate levels in the myocardium, thereby improving cardiac function and reducing ischemic damage. Originally established in Switzerland, the company operates as a specialized entity within the broader cardiovascular portfolio of its parent organization. Its products are widely utilized in clinical settings across Europe and Asia for the management of metabolic disturbances in the heart muscle.